-
News | 2016.11.30
3rd Institut Pasteur International Network Symposium celebrates Biomarkers
The opening ceremony of the Institut Pasteur International Network Symposium held on 29th of November at the Institut Pasteur Conference Center gathered nearly 350 participants. Building on the success of the two previous editions, the Symposium focuses this year on all research aspects that might potentially lead to the development of new biomarkers.In his opening speech, Christian Brechot,...
-
Vidéo | 2025.04.07
The comeback of measles
Measles explodes in 2025: what do we do?Nearly 200 cases in France this year, twice as many as last year! This ultra-contagious virus infects the respiratory tract before spreading throughout the body. 1 patient can infect 20 - as easily as a cold! Fever, cough, rash... but above all serious complications for 1 in 5 people: pneumonia, encephalitis, hospitalization, and babies at risk. Over a...
-
News | 2016.07.17
Malaria: a genetically attenuated parasite induces an effective, long-lasting immune response
With nearly 3.2 billion people currently at risk of contracting malaria, scientists from the Institut Pasteur, the CNRS and Inserm have experimentally developed a live, genetically attenuated vaccine for Plasmodium, the parasite responsible for the disease. By identifying and deleting one of the parasite's genes, the scientists enabled it to induce an effective, long-lasting immune response...
-
News | 2015.01.26
Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases
For 10 years, Total and its corporate foundation working alongside the Institut Pasteur and its International Network in the fight against infectious diseases. A new sponsorship agreement, of EUR 6 million for three years, was signed on 26 January 2015. It will provide funding, for public health and research projects in resource limited countries in order to better understand the therapeutic and...
-
News | 2015.07.29
A MOOC in vaccinology
A new MOOC developed by the Institut Pasteur will be launched on September 17, 2015. Thirty-one internationally renowned medicine professors, scientists, and public health professionals from many countries, will give a large overview of vaccinology: history, definitions, basic immunology, epidemiology, preclinical and clinical development, recent vaccines, and future challenges. This MOOC is...
-
News | 2015.09.06
World Sepsis Day: fighting deadly infections
On September 11, the Institut Pasteur will host a conference for World Sepsis Day (WSD). Sepsis is a condition triggered by a serious infection (usually bacterial but occasionally fungal, viral or parasitic) that attacks the body's vital functions. Despite modern medical advances in vaccinations, antibiotics and intensive care, there is still a high death rate among sepsis victims. Septicemia...
-
News | 2014.11.23
The Total Corporate Foundation and the Institut Pasteur launch a call for proposal on child health in resource limited countries
The Total Foundation Total and the Institut Pasteur has launched today a new call for proposal open until the 25th of next January as part of their long-lasting partnership. Specifically dedicated to the study of vaccine and/or therapeutic responses in children, this new call will support international research projects led by scientists belonging to the Institut Pasteur International...
-
News | 2017.07.19
Pertussis : progress but lack of surveillance
Whooping cough is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis, and which can be serious, or even fatal, for infants. Using a mathematical model, scientists from Honk Kong University and WHO have just published new estimates of the global weight of the disease. These new estimates indicate that the number of pertussis cases among children under 5 years of...
-
Report | 2017.07.24
AIDS: progress and fresh hope
Having claimed the lives of close to 40 million people (source: OMS 2017) since HIV was discovered in 1983, AIDS is indeed a global health catastrophe. Significant progress has nevertheless been made over the last few years, particularly in developed countries, with longer life expectancy for patients on triple therapy. But this treatment does not eliminate the virus and must be taken for life....
-
Article | 2020.06.16
Working towards controlled detection of SARS-CoV-2 by the innate immune system
Aim: controlling the SARS-CoV-2 outbreak requires both scientific knowledge and antiviral drugs. RIG-I-like receptors in the cell cytoplasm play a major role in detecting infection with RNA viruses and in initiating and modulating antiviral immunity. The aim of the project is to study the RNA ligands in the SARS-CoV-2 virus that are detected by these receptors. The project will shed light on...